Overview

The Global Pharma AI, Compliance & Technology Summit (GPACTS) will be held on 3 September 2026 at the Novotel Hyderabad Convention Centre (HICC). The flagship edition is expected to bring together 350‑400 senior decision‑makers from pharmaceutical technology, manufacturing, quality, compliance, data and cybersecurity functions.

Dignitaries and Leadership

The summit will feature A.V.P.S. Chakravarty, Chairman of the Federation of Pharma Entrepreneurs (FOPE), as Chief Guest. He will be accompanied by Dr. Sridhar Reddy, Honorary Secretary of the Indian Pharmaceutical Association (IPA), and Sarvesh Singh, CEO of Telangana Life Sciences, providing regulatory and state‑level perspectives.

Programme Focus

The agenda is designed to address responsible AI and governance in validated environments, evolving data‑protection requirements, manufacturing cybersecurity, digital batch processes, manufacturing execution systems, laboratory software, connected quality systems and digital twins. Unlike generic technology conferences, GPACTS concentrates on the realities of regulated pharmaceutical operations, fostering direct dialogue between enterprise technology leaders and manufacturing, quality and compliance functions.

Confirmed Speakers

Key speakers include:

  • Dr. Ajaz Hussain, former FDA Director
  • Ramanarayana Parhi, Vice President & CIO, Alkem Laboratories
  • Rajesh T, Digital Transformation Head, Dr. Reddy’s Laboratories
  • Dr. Deepa Pangaonkar, Vice President – Quality IT, Wockhardt
  • Karthick Raja, CIO, Granules India
  • Praveen Kumar Baheti, Vice President – IT, Biological E

Partner Ecosystem and Technology Sponsors

The Hyderabad edition is powered by Honeywell. Additional partners strengthening the summit’s focus on connected operations, automation and manufacturing intelligence are Rockwell Automation, Nividous Software, Thermo Fisher Scientific, Incep Bio, Abhiyanta Tech and Ample Logic.

Startup Showcase

A curated startup segment will feature NM Technokrafts, Wizmoid and AI4Pharma, bringing emerging solutions and specialised capabilities into direct conversation with senior pharma decision‑makers.

Organizer Commentary

“Pharma’s AI and digital‑transformation agenda can no longer be separated from manufacturing, quality and compliance. GPACTS is being built as the platform where the leaders responsible for these decisions can confront the operational and regulatory realities together—and move the conversation from ambition to accountable implementation,” said Shipra Singh, Founder and Director of GPACTS.

Reference to Prior Editions

Earlier editions in Mumbai and Ahmedabad collectively engaged 228 delegates and 32 speakers, with over 80 % representing pharma end‑user organisations. 40‑50 % of participants were from C‑suite or senior leadership roles. The Ahmedabad edition introduced a live ransomware tabletop simulation based on a pharmaceutical manufacturing environment, integrating technology, security and operational considerations.

Additional Organizer Insight

“The response in Mumbai and Ahmedabad confirmed that pharma leaders want more than broad transformation narratives. They want implementation insight, peer experience and honest discussion of risk. Hyderabad takes that model to its flagship scale by bringing AI, compliance, cybersecurity and manufacturing systems into one decision‑making forum,” said Ravindra Warang, Director of GPACTS.

Target Audience

The summit is intended for senior professionals from pharmaceutical manufacturing, IT, digital transformation, quality, compliance, data, automation and cybersecurity functions, as well as selected technology and advisory organisations serving regulated life‑sciences operations.

Registration

For programme details and registration, visit www.gpacts.com.

Media Contact

GPACTS Communications Team – Email: partnerships@gpacts.org.

---